Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Can methadone prolong the QT interval?

Decerf JA, Gressens B, Brohet C, Liolios A, Hantson P.

Intensive Care Med. 2004 Aug;30(8):1690-1. Epub 2004 Jun 8. No abstract available.

PMID:
15185068
2.

Methadone-associated QT prolongation and torsades de pointes.

George S.

Br J Hosp Med (Lond). 2007 Apr;68(4):221. No abstract available.

PMID:
17465110
3.

Methadone and QT prolongation in HIV-infected patients.

Lucchini A, Barbaro G, Barbarini G.

Am J Cardiol. 2004 Jul 1;94(1):147-8. No abstract available.

PMID:
15219532
4.

Methadone and QT prolongation: a dose-dependent effect?

Krantz MJ, Mehler PS.

Am J Cardiol. 2004 Apr 1;93(7):952. No abstract available.

PMID:
15050510
5.

Methadone-associated QT prolongation and torsades de pointes. Dubrey and Groscott-Mason's patient was underttreated for her atrial fibrillation.

Al-Sardar H.

Br J Hosp Med (Lond). 2007 Apr;68(4):221; author reply 221. No abstract available.

PMID:
17469230
6.

Re: Methadone in the management of intractable neuropathic noncancer pain.

Fayez K, Juan-Diego H, Oscar A de LC.

Can J Neurol Sci. 2006 Feb;33(1):116. No abstract available.

PMID:
16583735
7.

Medications that prolong the QT interval.

Krantz MJ, Martell BA, Arnsten JH, Gourevitch MN.

JAMA. 2003 Aug 27;290(8):1025; author reply 1026. No abstract available.

PMID:
12941668
8.

High-dose methadone and QTc prolongation: strategies to optimize safety.

Schmittner J, Krantz MJ.

J Opioid Manag. 2006 Jan-Feb;2(1):49-55. No abstract available.

PMID:
17319118
9.

Fluctuating QTc interval in an asymptomatic patient treated with methadone for chronic pain.

Ower K, Morley-Forster P, Moulin D.

J Opioid Manag. 2005 May-Jun;1(2):73-6.

PMID:
17319250
10.

Methadone and torsade de pointes: how can we better understand the association?

Hasnain M, Vieweg WV, Breden Crouse EL, Hancox JC.

Am J Med. 2013 Sep;126(9):757-8. doi: 10.1016/j.amjmed.2013.03.013. No abstract available.

PMID:
23968900
11.

Methadone and the QT interval: relations to the serum concentrations of methadone and its enantiomers (R)-methadone and (S)-methadone.

Skjervold B, Bathen J, Spigset O.

J Clin Psychopharmacol. 2006 Dec;26(6):687-9. No abstract available.

PMID:
17110841
12.

Opioid maintenance patients with QTc prolongation: congenital long QT syndrome mutation may be a contributing risk factor.

Anchersen K, Hansteen V, Gossop M, Clausen T, Waal H.

Drug Alcohol Depend. 2010 Dec 1;112(3):216-9. doi: 10.1016/j.drugalcdep.2010.06.015. Epub 2010 Aug 10.

PMID:
20702049
13.

[Long QT and torsade de pointes in a patient with acquired human immunodeficiency virus infection in multitherapy with drugs affecting cytochrome P450].

Hrovatin E, Zardo F, Brieda M, Dametto E, Piazza R, Antonini-Canterin F, Cassin M, Meneguzzo N, Viel E, Lestuzzi C, Di Gennaro G, Nicolosi GL.

Ital Heart J Suppl. 2004 Sep;5(9):735-40. Italian.

PMID:
15568612
14.

Torsades de pointes with methadone.

[No authors listed]

Prescrire Int. 2005 Apr;14(76):61-2.

PMID:
15875343
15.

[Methadone-induced heart arrhythmia].

Østvold C, Topper M.

Tidsskr Nor Laegeforen. 2005 Aug 11;125(15):2021-2. Norwegian.

16.

QT interval prolongation in patients on methadone with concomitant drugs.

Piguet V, Desmeules J, Ehret G, Stoller R, Dayer P.

J Clin Psychopharmacol. 2004 Aug;24(4):446-8. Review. No abstract available.

PMID:
15232338
17.

Effect of buprenorphine and antiretroviral agents on the QT interval in opioid-dependent patients.

Baker JR, Best AM, Pade PA, McCance-Katz EF.

Ann Pharmacother. 2006 Mar;40(3):392-6. Epub 2006 Feb 28.

PMID:
16507617
18.

Methadone-induced torsade de pointes in a patient with normal baseline QT interval.

Almehmi A, Malas AM, Yousufuddin M, Rosencrance JG.

W V Med J. 2004 Jul-Aug;100(4):147-8.

PMID:
15471174
19.

QTc prolongation: methadone's efficacy-safety paradox.

Krantz MJ, Mehler PS.

Lancet. 2006 Aug 12;368(9535):556-7. No abstract available.

PMID:
16905001
20.

Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors.

Ehret GB, Voide C, Gex-Fabry M, Chabert J, Shah D, Broers B, Piguet V, Musset T, Gaspoz JM, Perrier A, Dayer P, Desmeules JA.

Arch Intern Med. 2006 Jun 26;166(12):1280-7.

PMID:
16801510

Supplemental Content

Support Center